| Medication categories, N (%) | Headache Patients (N = 130) | Migraine patients (N = 91) | Non-Migraine patients (N = 39) |
| Antiepiletic drugs | 92 (70.8) | 64 (70.3) | 28 (71.8) |
| Triptans | 47 (36.2) | 41 (45.1) | 6 (15.4) |
| NSAIDS | 40 (30.8) | 32 (35.2) | 8 (20.5) |
| Tricyclic antidepressants | 47 (36.2) | 33 (36.3) | 14 (35.9) |
| SNRIs | 40 (30.8) | 28 (30.8) | 12 (30.8) |
| Opioids | 33 (25.4) | 23 (25.3) | 10 (25.6) |
| Beta blockers | 36 (27.7) | 32 (35.2) | 4 (10.3) |
| Botox | 27 (20.8) | 25 (27.5) | 2 (5.1) |
| Benzodiazepines | 23 (17.7) | 10 (11.0) | 13 (33.3) |
| Memantine | 22 (16.9) | 19 (20.9) | 3 (7.7) |
| Muscle relaxants | 18 (13.9) | 12 (13.2) | 6 (15.4) |
| SSRIs | 18 (13.9) | 15 (16.5) | 3 (7.7) |
| Number of medication categories | |||
| 1 | 20 (15.4) | 11 (12.1) | 9 (23.1) |
| 2 | 25 (19.2) | 17 (18.9) | 9 (20.5) |
| 3 | 28 (21.5) | 19 (20.9) | 9 (23.1) |
| 4 | 24 (18.5) | 15 (15.5) | 9 (23.1) |
| 5 | 13 (10.0) | 10 (11.0) | 9 (23.1) |
| 6 | 13 (10.0) | 12 (13.2) | 9 (23.1) |
| 7 | 6 (4.6) | 6 (6.6) | 23 (7.7) |
| 8 | 1 (0.8) | 1 (1.1) | 1 (2.6) |